NORTHWEST BIOTHERAPEUTICS LIMITED
- Legal registered address
- The St Botolph Building, 138 Houndsditch London United Kingdom EC3A 7AR
Latest financial results as of 26 July 2025- Cash in bank
- £4.28k
- Current assets
- £631.91k
- Current creditors
- £19.77m
- Shareholders funds
- £-10.37m
View full financial accounts- Cash in bank
- £4.28k
- Current assets
- £631.91k
- Current creditors
- £19.77m
- Shareholders funds
- £-10.37m
- Company number
- 09103355
Accounts
Latest annual accounts were to 31 December 2023
Next annual accounts are due by 30 September 2025
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 11 January 2025
Next statement due by 25 January 2026
Nature of business (SIC)
68209 - Other letting and operating of own or leased real estate
72110 - Research and experimental development on biotechnology
Previous company names
| Name | Date previous name changed |
|---|---|
| ARACARIS LIMITED | 24 July 2023 |
Latest company documents
| Date | Description |
|---|---|
| 20/03/2520 March 2025 | Confirmation statement made on 2025-01-11 with no updates |
| 30/09/2430 September 2024 | Total exemption full accounts made up to 2023-12-31 |
| 22/01/2422 January 2024 | Registered office address changed from Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom to The St Botolph Building, 138 Houndsditch London EC3A 7AR on 2024-01-22 |
| 19/01/2419 January 2024 | Confirmation statement made on 2024-01-11 with no updates |
| 19/01/2419 January 2024 | Withdrawal of a person with significant control statement on 2024-01-19 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company